PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 26, 2026Nature Communications0 citationsOpen Access

The nuclease EXO1 promotes genomic instability by degrading nascent DNA in BRCA-proficient cells

ANAlexandra NusawardhanaCNClaudia M. NicolaeGMGeorge‐Lucian Moldovan

Key Points

  • The central aim is to investigate how EXO1 activity contributes to genomic instability in BRCA-proficient cells.
  • Analyzed EXO1 expression levels in tumors.
  • Examined nascent DNA degradation at ssDNA gaps and reversed replication forks.
  • Studied the cooperation of EXO1 with MRE11 in BRCA-proficient cells.
  • EXO1 is overexpressed in a significant number of tumors.
  • EXO1 causes degradation of nascent DNA, leading to increased double strand breaks.
  • Cells with high EXO1 activity show hypersensitivity to genotoxic agents.

Abstract

Abstract DNA repair genes are generally considered tumor suppressors, as their inactivation is observed in tumors and is associated with carcinogenesis. Mutations in BRCA1 and BRCA2 genes are observed in breast, ovarian, and other cancers. This results in defective homologous recombination DNA repair, as well as in degradation of nascent DNA during replication stress, catalyzed by exonucleases including EXO1 and MRE11. However, most tumors are BRCA pathway-proficient. Here, we show that EXO1 is overexpressed in a significant proportion of tumors. EXO1 overexpression causes the degradation of nascent DNA at both single stranded DNA (ssDNA) gaps and reversed replication forks. Importantly, this degradation occurs efficiently in BRCA-proficient cells, through cooperation with MRE11. This results in increased double strand break formation and hypersensitivity to genotoxic agents. We thus identify increased EXO1 activity as a mechanism of genomic instability similar to BRCA pathway inactivation, but occurring more frequently in tumors compared to BRCA inactivation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nusawardhana et al. (2026) studied this question.

synapsesocial.com/papers/699fe40c95ddcd3a253e83c1https://doi.org/10.1038/s41467-026-69981-1
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The KU-PARP14 axis differentially regulates DNA resection at stalled replication forks by MRE11 and EXO12022 · 49 citations
  2. 2Single Cell Analysis of Human RAD18-Dependent DNA Post-Replication Repair by Alkaline Bromodeoxyuridine Comet Assay2013 · 32 citations
  3. 3Breast Tumors with Elevated Expression of 1q Candidate Genes Confer Poor Clinical Outcome and Sensitivity to Ras/PI3K Inhibition2013 · 71 citations
  4. 4Accumulation of driver and passenger mutations during tumor progression2010 · 858 citations
  5. 5Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy2019 · 496 citations